联康生物科技集团有限公司（00690）于2025年12月3日发布2025年11月股份变动月报表。本报告期自2025年11月1日至11月30日，公司注册股本合计维持在港币50亿，面值港币0.01元，未发生增减变动。
截至2025年11月30日，公司普通股已发行股份总数为5,971,228,147股，与上月持平，未见新增发行、购回及注销或库藏股活动。各项已授出的股份期权同样无行使及失效变动，数量保持不变。
公司在公告中确认，该期间的所有发行及股份相关事宜已获董事会正式授权批准，并遵守香港联交所《上市规则》及当地相关法律法规。公告由公司秘书何咏欣女士签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.